Obstetric and Gynecologic Imaging

What Is the Best Initial Imaging for Ovarian Reserve in Female Infertility?

·
What Is the Best Initial Imaging for Ovarian Reserve in Female Infertility?

A 32-year-old G0P0 presents with her partner to your primary care clinic. They have been trying to conceive for 14 months without success. Her menstrual cycles are regular, and she has no significant medical history, but she is increasingly anxious about her “biological clock.” You have initiated the basic workup, including partner semen analysis and hormonal labs. Now you must decide on the appropriate initial imaging to assess her ovarian function and reserve. This article details the American College of Radiology (ACR) workflow for this specific clinical question: the initial imaging evaluation of ovulatory function and ovarian reserve in female infertility. For this scenario, the ACR rates both US pelvis transabdominal and US pelvis transvaginal as Usually appropriate.

Who Fits This Clinical Scenario?

This guidance applies to female patients presenting with infertility, defined as the inability to achieve pregnancy after 12 months of regular, unprotected intercourse (or 6 months for women over age 35). The central clinical question is the assessment of ovarian reserve—the quantity and quality of remaining oocytes—and the evaluation of basic ovarian and uterine morphology as it relates to ovulatory function. This is often one of the first steps in the infertility workup, performed alongside biochemical testing like anti-Müllerian hormone (AMH) and day 3 follicle-stimulating hormone (FSH) levels.

This workflow is specifically for the initial evaluation where the primary concern is ovarian reserve. It is distinct from scenarios where a specific diagnosis is already suspected. This guidance does not apply if:

  • The patient has clear clinical features of Polycystic Ovary Syndrome (PCOS): If the patient presents with hirsutism, acne, and irregular menses, the imaging approach is tailored to confirming polycystic ovarian morphology within the context of the Rotterdam criteria.
  • There is a strong clinical suspicion of endometriosis: Patients with significant dysmenorrhea, dyspareunia, or a palpable adnexal mass suggestive of an endometrioma follow a different diagnostic pathway.
  • Tubal occlusion is the primary concern: If the patient has a history of pelvic inflammatory disease (PID), pelvic surgery, or other risk factors for tubal damage, a hysterosalpingogram (HSG) is the primary imaging modality, not pelvic ultrasound.

What Diagnoses Are You Working Up in This Scenario?

When ordering initial imaging for ovarian reserve, you are primarily investigating factors that predict a patient’s response to fertility treatments and overall reproductive potential. The differential diagnosis includes several key possibilities.

Diminished Ovarian Reserve (DOR): This is the most common and critical diagnosis to assess. DOR refers to a reduction in the quantity of oocytes. While age is the strongest predictor, some women experience DOR earlier than expected. Ultrasound provides a direct, real-time assessment of the antral follicle count (AFC), which is a strong surrogate marker for the primordial follicle pool. A low AFC is a key indicator of DOR and helps guide counseling and treatment decisions.

Polycystic Ovarian Morphology (PCOM): Even in women with regular cycles, the ovaries may exhibit polycystic morphology (increased follicle number per ovary, increased ovarian volume). While PCOM is a component of PCOS, its presence alone can be clinically significant, sometimes associated with a higher risk of ovarian hyperstimulation syndrome (OHSS) during fertility treatments. Ultrasound is the definitive modality for identifying PCOM.

Incidental Anatomic Abnormalities: The initial ultrasound serves as a crucial screening tool for structural issues that could impact fertility or pregnancy. This includes common findings like uterine leiomyomas (fibroids), particularly those that are submucosal or intracavitary and distort the endometrial cavity. It can also detect adenomyosis or congenital uterine anomalies (e.g., septate or bicornuate uterus) that may not have been previously diagnosed.

Adnexal Masses: While less common as a primary cause of ovulatory dysfunction, other ovarian pathologies can be discovered. This includes benign cysts, endometriomas (which would shift the workup toward the endometriosis scenario), or other benign or malignant neoplasms that could affect ovarian function or require intervention before fertility treatment can proceed.

Why Is Pelvic Ultrasound the Recommended Initial Study?

The ACR Appropriateness Criteria rate both US pelvis transabdominal and US pelvis transvaginal as Usually appropriate for the initial evaluation of ovarian reserve. These are not mutually exclusive studies but rather complementary components of a single, comprehensive pelvic ultrasound examination. The procedure is safe, with no ionizing radiation (0 mSv), and provides an exceptional level of detail for the clinical questions at hand.

The transabdominal approach provides a wide field of view, allowing for a general survey of the pelvis, assessment of the uterus size and contour, and detection of large adnexal masses that might be missed on a limited transvaginal view. The transvaginal portion is the cornerstone of the evaluation, using a high-frequency transducer placed in the vaginal fornix to obtain high-resolution images of the ovaries, endometrium, and myometrium.

This combined approach is superior for this scenario because it directly addresses the key diagnostic questions:

  • Antral Follicle Count (AFC): Transvaginal ultrasound is the gold standard for performing an AFC, which involves counting the number of small (2-10 mm) follicles in each ovary during the early follicular phase of the menstrual cycle. This count correlates directly with ovarian reserve.
  • Ovarian Morphology and Volume: The study allows for precise measurement of ovarian volume and assessment for polycystic morphology, as defined by the number of follicles and/or increased volume.
  • Uterine and Endometrial Assessment: It provides a detailed evaluation of the endometrial lining thickness and pattern, and can identify uterine fibroids, polyps, or congenital anomalies that could interfere with implantation.

Alternative Modalities:

  • MRI pelvis without IV contrast is rated as May be appropriate. It is not a first-line tool for ovarian reserve because it is more expensive, less available, and does not offer a significant advantage over ultrasound for follicle counting. Its role is reserved for problem-solving—for instance, to better characterize a uterine anomaly or an indeterminate adnexal mass found on ultrasound.
  • MRI pelvis without and with IV contrast is rated Usually not appropriate. The addition of gadolinium-based contrast adds cost and potential risk (e.g., in patients with renal insufficiency) without providing any additional clinically useful information for the specific question of ovulatory function or ovarian reserve.

What’s Next After Pelvic Ultrasound? Downstream Workflow

The results of the pelvic ultrasound will guide the subsequent steps in the patient’s infertility evaluation and management plan. The workflow branches based on the key findings.

  • If the study suggests Diminished Ovarian Reserve (low AFC): This finding, especially when correlated with abnormal hormonal markers (low AMH, high FSH), prompts a serious discussion with the patient about her reproductive potential. The next step is typically a referral to a reproductive endocrinologist. Management may involve counseling about the decreased likelihood of success with simpler treatments and moving more quickly toward advanced options like in vitro fertilization (IVF).
  • If the study is normal (reassuring AFC, normal anatomy): A normal ultrasound is reassuring but does not complete the infertility workup. It effectively rules out a significant ovarian reserve or uterine anatomic issue as the primary cause. The investigation must then focus on other potential causes. The next logical step is often to evaluate tubal patency, which falls under a different ACR scenario: Female infertility. Suspicion of tubal occlusion. This typically involves a hysterosalpingogram (HSG) or a saline-infusion sonohysterogram (SIS).
  • If the study is indeterminate or reveals a complex finding: When ultrasound identifies a finding that cannot be fully characterized, such as a suspected congenital uterine anomaly or a complex adnexal mass, the downstream pathway often involves the May be appropriate study: MRI pelvis without IV contrast. MRI offers superior soft tissue contrast and multiplanar imaging capabilities to definitively characterize uterine anatomy or differentiate between various types of adnexal masses (e.g., endometrioma vs. hemorrhagic cyst vs. neoplasm).

Pitfalls to Avoid (and When to Get Help)

Navigating the initial infertility workup requires attention to detail to avoid common missteps that can delay diagnosis or lead to incorrect conclusions.

1. Incorrect Timing of the Scan: For an accurate antral follicle count, the ultrasound must be performed in the early follicular phase (typically cycle days 2-5). A scan performed mid-cycle or in the luteal phase can be misleading due to the presence of a dominant follicle or corpus luteum, making an accurate AFC impossible.
2. Equating PCOM with PCOS: Identifying polycystic ovarian morphology (PCOM) on ultrasound is only one of three potential criteria for Polycystic Ovary Syndrome (PCOS). Do not diagnose PCOS based on imaging alone. The diagnosis requires at least two of the following: PCOM, oligo- or anovulation, and clinical or biochemical hyperandrogenism.
3. Forgetting the Global View: Focusing solely on the transvaginal images of the ovaries can cause you to miss a large pedunculated fibroid or an ovarian mass located high in the pelvis. Always ensure a complete examination includes the transabdominal survey.

If the ultrasound reveals a suspicious adnexal mass with features concerning for malignancy (e.g., solid components, thick septations, significant vascularity), the appropriate next step is to escalate care with a referral to a gynecologic oncologist and consider a contrast-enhanced pelvic MRI for further characterization.

Related ACR Topics and Tools

This article covers one specific scenario in the evaluation of female infertility. For a comprehensive overview of all related clinical variants and their recommended imaging pathways, please consult our parent guide. For additional resources to help refine your imaging orders, see the tools below.

Frequently Asked Questions

Why are both transabdominal and transvaginal ultrasound listed as ‘Usually Appropriate’?

They are considered complementary parts of a single, comprehensive pelvic ultrasound examination. The transabdominal approach provides a broad overview of the pelvis to assess uterine size and detect large masses, while the transvaginal approach provides high-resolution detail of the ovaries for follicle counting and evaluation of the endometrium.

Does the timing of the ultrasound matter for evaluating ovarian reserve?

Yes, timing is critical. To get an accurate antral follicle count (AFC), the ultrasound should be performed in the early follicular phase of the menstrual cycle, typically between day 2 and day 5. Performing the scan at other times can lead to an inaccurate assessment.

What is an antral follicle count (AFC) and what is considered normal?

The antral follicle count is the total number of small follicles (measuring 2-10 mm) visible in both ovaries on ultrasound. It is a key marker of ovarian reserve. While ‘normal’ varies significantly with age, a total AFC of 7-10 or greater is often considered reassuring, while a count below 5-7 may suggest diminished ovarian reserve.

If the ultrasound is normal, does that mean my patient is fertile?

Not necessarily. A normal ultrasound for ovarian reserve is an important and reassuring finding, but it is only one piece of the complex infertility puzzle. Fertility also depends on tubal patency, male factor, and other ovulatory and uterine factors that may not be visible on a standard ultrasound. Further investigation, such as a hysterosalpingogram (HSG) to check the fallopian tubes, is often required.

When should I order an MRI instead of an ultrasound for this workup?

MRI is not a first-line tool for assessing ovarian reserve. Its primary role in this context is for problem-solving. You should consider ordering an MRI pelvis without contrast if the ultrasound is inconclusive, such as when a congenital uterine anomaly (e.g., septate uterus) is suspected or if there is an indeterminate adnexal mass that requires more detailed characterization.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026